01541.HK
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 3.40
+0.29%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.92x
- Price / sales
- 4.38x
- Price / cash flow
- -5.76x
Enterprise value
- Enterprise value
- HKD 718.7M
- EV / sales
- 2.24x
- EV / EBITDA
- -1.23x
- EV / EBIT
- -1.20x
- Market cap
- HKD 1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026